Does Time to Retreatment Matter? A Normal Tissue Complication Probability Model to Predict Radionecrosis After Repeat Stereotactic Radiosurgery for Recurrent Brain Metastases Incorporating Time-dependent Discounted Dose
International Journal of Radiation Oncology*Biology*Physics · 2025-06 · 122 (2) · 467-475
DOI: 10.1016/j.ijrobp.2025.01.017 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Radiation Oncology*Biology*Physics, 2025-06. Verfasst von Manju Sharma und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, University of California San Francisco, San Francisco, California. Electronic address: manju.sharma@ucsf.edu. Hauptthemen laut MEDLINE: Brain Neoplasms, Radiosurgery, Radiation Injuries, Neoplasm Recurrence, Local. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: UCSF.
Abstract (Originalsprache)
PURPOSE: To develop and compare normal tissue complication probability (NTCP) models for recurrent brain metastases (BMs) treated with repeat single-fraction stereotactic radiosurgery (SRS), considering time-dependent discounted prior dose. METHODS AND MATERIALS: We developed three NTCP models (M0, M1-retreat, and M1-combo models) of BMs treated with GammaKnife-based SRS. The maximum dose is 0.2 cc (D0.2cc) of the lesion-specific brain, and the 1-year radionecrosis risk is modeled using a logistic response with doses converted into equivalent dose in 2-Gy fractions (EQD2) based on a linear quadratic linear model. The M0 and M1-retreat models, respectively, predicted radionecrosis risk after SRS to 1029 nonrecurrent lesions (patients, 262) and second SRS to 149 recurrent lesions (patients, 87). The M1-combo model accounted for the second SRS and time-dependent discounted first SRS dose for recurrent lesions estimated using a modified Gompertzian function. RESULTS: All 3 models fitted the data well (χ2, 0.039-0.089, and P = 0.999-1.000). The fitted EQD250 was ∼ 103 Gy for the M0 model, ∼ 88 Gy for the M1-retreat model, and ∼ 165 Gy for the M1-combo model. The fitted γ50 exhibited a progressively flatter dose-response curve across the three models, with values of 1.2 per gray for the M0 model, 0.6 per gray for the M1-retreat model, and 0.4 per gray for the M1-combo model. For the brain D0.2cc of 29 and 19 Gy, the steepest to shallowest dose-response or largest change in NTCP values, ie, NTCP29Gy - NTCP19Gy, was observed in the M1-retreat (0.16), M0 (0.14), and M1-combo (0.06) models. CONCLUSIONS: The model-fitted parameters predicted that recurrent BMs would have a lower threshold dose tolerance and a more gradual dose response to the second SRS than nonrecurrent BMs. This gradual dose-response becomes even more apparent when considering the time-dependent discounted first SRS as a cumulative second SRS. Tailoring SRS retreatment protocols based on NTCP modeling can potentially enhance therapeutic efficacy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Radiation Oncology, University of California San Francisco, San Francisco, California. Electronic address: manju.sharma@ucsf.edu.
- Department of Machine Learning, Moffitt Cancer Center, Tampa, Florida.
- Department of Radiation Oncology, University of California San Francisco, San Francisco, California.
Förderung
- UCSF
Zitieren
APA
Sharma, M., Naqa, I. E., & Sneed, P. K. (2025). Does Time to Retreatment Matter? A Normal Tissue Complication Probability Model to Predict Radionecrosis After Repeat Stereotactic Radiosurgery for Recurrent Brain Metastases Incorporating Time-dependent Discounted Dose. International Journal of Radiation Oncology*Biology*Physics, 122(2), 467-475. https://doi.org/10.1016/j.ijrobp.2025.01.017
Vancouver
Sharma M, Naqa IE, Sneed PK. Does Time to Retreatment Matter? A Normal Tissue Complication Probability Model to Predict Radionecrosis After Repeat Stereotactic Radiosurgery for Recurrent Brain Metastases Incorporating Time-dependent Discounted Dose. International Journal of Radiation Oncology*Biology*Physics. 2025;122(2):467-475. doi:10.1016/j.ijrobp.2025.01.017
BibTeX
@article{Sharma2025,
author = {Sharma, Manju and Naqa, Issam El and Sneed, Penny K},
title = {Does Time to Retreatment Matter? A Normal Tissue Complication Probability Model to Predict Radionecrosis After Repeat Stereotactic Radiosurgery for Recurrent Brain Metastases Incorporating Time-dependent Discounted Dose},
journal = {International Journal of Radiation Oncology*Biology*Physics},
year = {2025},
volume = {122},
number = {2},
pages = {467--475},
doi = {10.1016/j.ijrobp.2025.01.017}
}
EUVIMED